Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 4.855 SEK 4.07% Market Closed
Market Cap: 563.3m SEK

Wall Street
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 8.925 SEK with a low forecast of 6.565 SEK and a high forecast of 11.55 SEK.

Lowest
Price Target
6.565 SEK
35% Upside
Average
Price Target
8.925 SEK
84% Upside
Highest
Price Target
11.55 SEK
138% Upside
Ascelia Pharma AB Competitors:
Price Targets
IMMX
Immix Biopharma Inc
201% Upside
LYEL
Lyell Immunopharma Inc
94% Downside
GILD
Gilead Sciences Inc
4% Upside
TSVT
2Seventy Bio Inc
2% Upside
086900
Medy Tox Inc
29% Upside
688278
Xiamen Amoytop Biotech Co Ltd
36% Upside
IONS
Ionis Pharmaceuticals Inc
66% Upside
STOK
Stoke Therapeutics Inc
105% Upside

Revenue
Forecast

Revenue Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACE's stock price target?
Price Target
8.925 SEK

According to Wall Street analysts, the average 1-year price target for ACE is 8.925 SEK with a low forecast of 6.565 SEK and a high forecast of 11.55 SEK.

Back to Top